{
     "PMID": "12890707",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20040604",
     "LR": "20140611",
     "IS": "0007-1188 (Print) 0007-1188 (Linking)",
     "VI": "139",
     "IP": "7",
     "DP": "2003 Aug",
     "TI": "Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors.",
     "PG": "1281-8",
     "AB": "(1) Using in vivo intracerebral microdialysis in conscious, freely moving rats, we examined the effect of flibanserin, a potential antidepressant drug with high affinity for human 5-HT(1A) receptors and four-50-fold lower affinity for 5-HT(2A) and D(4) receptors, on basal extracellular concentrations of serotonin (5-hydroxytryptamine, 5-HT), dopamine (DA) and noradrenaline (NA) in selected regions of the rat brain. (2) Flibanserin at 3 and 10 mg kg(-1) significantly reduced extracellular 5-HT in the prefrontal cortex (by 30 and 45%) and dorsal raphe (35 and 44%), but had no effect on extracellular 5-HT in the ventral hippocampus. The 3 and 10 mg kg(-1) doses raised extracellular NA to a similar extent in the prefrontal cortex (47 and 50%). In all, 10 mg kg(-1) raised extracellular DA in the prefrontal cortex (63%) whereas 3 mg kg(-1) had no significant effect. (3) Pretreatment with the selective 5-HT(1A) receptor antagonist WAY100,635 (0.3 mg kg(-1)) 30 min before 10 mg kg(-1) flibanserin completely antagonized the latter's effects on extracellular 5-HT, DA and NA in the prefrontal cortex. WAY100,635 by itself had no effect on cortical extracellular monoamines. (4) The results show that the stimulation of 5-HT(1A) receptors plays a major role in the effect of flibanserin on brain extracellular 5-HT, DA and NA.",
     "FAU": [
          "Invernizzi, Roberto William",
          "Sacchetti, Giuseppina",
          "Parini, Stefania",
          "Acconcia, Sabrina",
          "Samanin, Rosario"
     ],
     "AU": [
          "Invernizzi RW",
          "Sacchetti G",
          "Parini S",
          "Acconcia S",
          "Samanin R"
     ],
     "AD": "Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milano, Italy. rinvernizzi@marionegri.it",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "England",
     "TA": "Br J Pharmacol",
     "JT": "British journal of pharmacology",
     "JID": "7502536",
     "RN": [
          "0 (Antidepressive Agents)",
          "0 (Benzimidazoles)",
          "0 (Piperazines)",
          "0 (Pyridines)",
          "112692-38-3 (Receptor, Serotonin, 5-HT1A)",
          "333DO1RDJY (Serotonin)",
          "37JK4STR6Z (flibanserin)",
          "71IH826FEG",
          "(N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxa",
          "mide)",
          "VTD58H1Z2X (Dopamine)",
          "X4W3ENH1CV (Norepinephrine)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antidepressive Agents/administration & dosage/*pharmacokinetics",
          "Benzimidazoles/administration & dosage/antagonists & inhibitors/*pharmacokinetics/*pharmacology",
          "Dopamine/*chemistry/metabolism",
          "Extracellular Fluid/chemistry",
          "*Forecasting",
          "Hippocampus/chemistry/drug effects/metabolism",
          "Injections, Subcutaneous",
          "Male",
          "Microdialysis/methods",
          "Norepinephrine/*chemistry/metabolism",
          "Piperazines/administration & dosage/pharmacokinetics",
          "Prefrontal Cortex/*chemistry/drug effects/secretion",
          "Pyridines/administration & dosage/pharmacokinetics",
          "Raphe Nuclei/chemistry/drug effects/metabolism",
          "Rats",
          "Rats, Sprague-Dawley",
          "Receptor, Serotonin, 5-HT1A/drug effects/physiology",
          "Serotonin/*chemistry/metabolism"
     ],
     "PMC": "PMC1573953",
     "EDAT": "2003/08/02 05:00",
     "MHDA": "2004/06/05 05:00",
     "CRDT": [
          "2003/08/02 05:00"
     ],
     "PHST": [
          "2003/08/02 05:00 [pubmed]",
          "2004/06/05 05:00 [medline]",
          "2003/08/02 05:00 [entrez]"
     ],
     "AID": [
          "10.1038/sj.bjp.0705341 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Br J Pharmacol. 2003 Aug;139(7):1281-8. doi: 10.1038/sj.bjp.0705341.",
     "term": "hippocampus"
}